Registered entities
Tscan Therapeutics, Inc.
Reg. No. 82-5282075United States
TSCAN THERAPEUTICS INC.
Reg. No. 825282075United States
Innovation
28 patent families (8 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace accelerating. Cited 196 times.
| Year | Filings |
|---|---|
| 2021 | 1 |
| 2022 | 9 |
| 2023 | 14 |
| 2024 | 15 |
| 2025 | 15 |
| 2026 | 4 |
Social engagement
Social engagement: 11.4K social following, 9 posts in the last 12 months — below the industry typical range.
Investor mix
11 investors on record; lead investors include Novartis, Pitango, Astellas Venture Management, 6 Dimensions Capital; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 7 | 64% |
| Bank & private debt | 1 | 9% |
| Other / undisclosed | 3 | 27% |
Hiring activity
Hires occasionally
1 role tracked across 1 of the last 12 months
6 May 2026 · Senior Manager, QA Operations · Waltham
Based on job postings tracked across public sources.
Recent activity
8 Jun 2026
Event
5th annual Wellness Expo
3 Jun 2026
Partnership
Cellares
26 May 2026
Product launch
Corporate website